Skip to main content

Spire Wealth Management

Position in NBIX — Neurocrine Biosciences Inc

CIK 1858740 MCLEAN, VA

Position in NBIX

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$116,292
+$111,155 QoQ
Shares Held
690
+1669.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#619
of 768 holders
Holding Since
Mar 2021
22 quarters on record

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Spire Wealth Management holds $860,691 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (13.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
690 $116,292

All Filings in NBIX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $116,292 690
2026-03-31 $5,137 39
2025-12-31 $5,531 39
2025-09-30 $15,301 109
2025-06-30 $14,831 118
2025-03-31 $21,456 194
2024-12-31 $26,754 196
2024-09-30 $22,813 198
2024-06-30 $27,258 198
2024-03-31 $18,757 136
2023-12-31 $20,159 153
2023-09-30 $8,212 73
2023-06-30 $36,682 389
2023-03-31 $38,362 379
2022-12-31 $14,930 125
2022-09-30 $11,683 110
2022-06-30 $11,210 115
2022-03-31 $10,312 110
2021-12-31 $10,816 127
2021-09-30 $29,732 310
2021-06-30 $30,169 310
2021-03-31 $57,669 593